loader

World Tenders & Procurement Opportunities

Search
Advanced Search

320391- Germany – Pharmaceutical products – Open house drug discount agreements for the active ingredient denosumab, trade name Xgeva, ATC M05BX04

World Biggest Tenders Source

This tender with title 320391- Germany – Pharmaceutical products – Open house drug discount agreements for the active ingredient denosumab, trade name Xgeva, ATC M05BX04 has been published on Bidding Source portal dated 20 May 2025 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

320391- Germany – Pharmaceutical products – Open house drug discount agreements for the active ingredient denosumab, trade name Xgeva, ATC M05BX04
Invitation for Bids
320391
Germany
20 May 2025
30 Apr 2027
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

321919- Germany – Pharmaceutical products – Open house drug discount agreements for the active ingredient denosumab, trade name Prolia, ATC M05BX04 Germany 321743- Germany – Pharmaceutical products – Open house drug discount agreements for the active ingredient peginterferon alfa-2a, ATC L03AB11 Germany 320283- Germany – Pharmaceutical products – Open house drug discount agreements for the active ingredient Risankizumab, ATC L04AC18 Germany 319216- Germany – Pharmaceutical products – Open house drug discount agreements for the active ingredient Bimekizumab, ATC L04AC21 Germany 318670- Germany – Pharmaceutical products – Medicines containing the active ingredient Axitinib (ATC: L01EK01) Germany 318604- Germany – Pharmaceutical products – Open house drug discount agreements for the active ingredient Axitinib, ATC L01EK01 Germany 322201- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 SGB V for the active ingredients mentioned with the option of concluding the agreement within the framework of the so-called open house procedure. Germany 321053- Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a, Paragraph 8 of the Social Code Book V (SGB V) through an open-house model for the active ingredient ustekinumab (ATC code according to WHO: L04AC05) Germany 315373- Germany – Pharmaceutical products – Open house drug discount contracts Ticagrelor, ATC B01AC24 Germany 307018- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V for medicinal products containing the active ingredient octreotide, in a dosage form with delayed release (ATC Code: H01CB02). Germany
Pharmaceutical products Tenders
Germany Tenders
Europe Tenders
Tenders
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans